K Number
K120241
Device Name
LINEAR HIP STEM, SIZE 5
Date Cleared
2012-02-24

(28 days)

Product Code
Regulation Number
888.3358
AI/MLSaMDIVD (In Vitro Diagnostic)TherapeuticDiagnosticis PCCP Authorized
Intended Use
The indications for use of the total hip replacement prosthesis include: noninflammatory degenerative joint disease including osteoarthritis and avascular necrosis; rheumatoid arthritis; correction of functional deformity; revision procedures where other treatments or devices have failed; and treatment of nonunion, femoral neck and trochanteric fractures of the proximal femur with head involvement, which is unmanageable using other techniques. This stem is to be press-fit.
Device Description
The Linear Porous Coated Hip Stem is fabricated from wrought/forged Ti-6Al-4V. It is collarless and has a Morse type taper to receive modular heads. This stem is available with a standard offset and a lateralized offset version that provides additional lateralization of the patient's femur without increasing leg length. The stem/neck angle is 135°. This change will add an alternate porous coating.
More Information

No
The summary describes a mechanical hip stem prosthesis and its materials, with no mention of software, algorithms, or any AI/ML related terms or concepts.

Yes
The device, a total hip replacement prosthesis, is intended to treat various medical conditions such as degenerative joint disease, rheumatoid arthritis, and fractures, which aligns with the definition of a therapeutic device.

No
This device is a total hip replacement prosthesis, which is an implant used for treatment, not for diagnosing a condition.

No

The device description clearly states it is a physical hip stem fabricated from Ti-6Al-4V, which is a hardware component.

No, this device is not an IVD (In Vitro Diagnostic).

Here's why:

  • IVD Definition: In vitro diagnostics are tests performed on samples taken from the human body, such as blood, urine, or tissue, to detect diseases, conditions, or infections. They are used to provide information for diagnosis, monitoring, or screening.
  • Device Description: The provided description is for a total hip replacement prosthesis, specifically a hip stem. This is an implantable medical device used to replace a damaged hip joint.
  • Intended Use: The intended use clearly states it's for treating conditions affecting the hip joint and proximal femur, such as osteoarthritis, rheumatoid arthritis, and fractures. This involves surgical implantation, not laboratory testing of bodily samples.

The information provided describes a surgical implant, not a diagnostic test performed outside the body.

N/A

Intended Use / Indications for Use

The indications for use of the total hip replacement prosthesis include: noninflammatory degenerative joint disease including osteoarthritis and avascular necrosis; rheumatoid arthritis; correction of functional deformity; revision procedures where other treatments or devices have failed; and treatment of nonunion, femoral neck and trochanteric fractures of the proximal femur with head involvement, which is unmanageable using other techniques. This stem is to be press-fit.

Product codes

LPH, LZO

Device Description

The Linear Porous Coated Hip Stem is fabricated from wrought/forged Ti-6Al-4V. It is collarless and has a Morse type taper to receive modular heads. This stem is available with a standard offset and a lateralized offset version that provides additional lateralization of the patient's femur without increasing leg length. The stem/neck angle is 135°. This change will add an alternate porous coating.

Mentions image processing

Not Found

Mentions AI, DNN, or ML

Not Found

Input Imaging Modality

Not Found

Anatomical Site

Hip joint, proximal femur

Indicated Patient Age Range

Not Found

Intended User / Care Setting

Not Found

Description of the training set, sample size, data source, and annotation protocol

Not Found

Description of the test set, sample size, data source, and annotation protocol

Not Found

Summary of Performance Studies (study type, sample size, AUC, MRMC, standalone performance, key results)

Non-Clinical Testing: Fatigue testing of the size 5 stem demonstrated the device's ability to perform under expected conditions. Prior testing of the alternate porous coating in K081679 included shear strength, tensile strength, shear fatigue strength, and rotating beam fatigue.

Clinical Testing: None provided.

Key Metrics (Sensitivity, Specificity, PPV, NPV, etc.)

Not Found

Predicate Device(s)

K991325, K081679

Reference Device(s)

Not Found

Predetermined Change Control Plan (PCCP) - All Relevant Information

Not Found

§ 888.3358 Hip joint metal/polymer/metal semi-constrained porous-coated uncemented prosthesis.

(a)
Identification. A hip joint metal/polymer/metal semi-constrained porous-coated uncemented prosthesis is a device intended to be implanted to replace a hip joint. The device limits translation and rotation in one or more planes via the geometry of its articulating surfaces. It has no linkage across the joint. This generic type of device has a femoral component made of a cobalt-chromium-molybdenum (Co-Cr-Mo) alloy or a titanium-aluminum-vanadium (Ti-6Al-4V) alloy and an acetabular component composed of an ultra-high molecular weight polyethylene articulating bearing surface fixed in a metal shell made of Co-Cr-Mo or Ti-6Al-4V. The femoral stem and acetabular shell have a porous coating made of, in the case of Co-Cr-Mo substrates, beads of the same alloy, and in the case of Ti-6Al-4V substrates, fibers of commercially pure titanium or Ti-6Al-4V alloy. The porous coating has a volume porosity between 30 and 70 percent, an average pore size between 100 and 1,000 microns, interconnecting porosity, and a porous coating thickness between 500 and 1,500 microns. The generic type of device has a design to achieve biological fixation to bone without the use of bone cement.(b)
Classification. Class II.

0

/2024|

510(k) Summary

Date: February 24, 2012

Manufacturer: Encore Medical, L.P. 9800 Metric Blvd Austin, TX 78758

Contact Person: Teffany Hutto Manager, Regulatory Affairs Phone: (512) 834-6255 Fax: (512) 834-6313 Email: teffany.hutto@djosurgical.com

| .
Comments of Children Comments of Children Comments of Children and Children
"onner
to the first and the collection to the considered to the summer of the many of the first and the many of the many of the many of the many of the many of the many of the many | ------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
THE OWN FORD I AN AND OLD OF THE CHILIP OF OF


68.04 €1 9
0 9 8 8 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6 6

A SEAL A CLAIM OF LEASE OF A CARRES OF A CARS.

A claim and a station and states and any and
------------------------------------------------------------------------------------------------------------------------------------------------------------------------------ | And Research and Cattle. |
|-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
| mon
2110
A - A -- A ------------------------------------------------------------------------------------------------------------------------------------------------------------------- | 100
ﮯ ﻟﯿﻨﮉﯾﺎ ﮨﺎ
------------------------------------------------------------------------------------------------------------------------------------------------------------------------------ | Acres of the first to the first the first the first the first the first the first the first the first the first the first the first the first the first the first the first th
Separe of the Area Area All |
| | ------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
***** * | |

Product CodeRegulation and Classification Name
LPHHip joint metal/polymer/metal semi-constrained porous coated uncemented prosthesis per 21 CFR 888.3358
LZOHip joint metal/ceramic/polymer semi-constrained cemented or nonporous uncemented prosthesis. per 21
CFR 888.3353

Description: The Linear Porous Coated Hip Stem is fabricated from wrought/forged Ti-6Al-4V. It is collarless and has a Morse type taper to receive modular heads. This stem is available with a standard offset and a lateralized offset version that provides additional lateralization of the patient's femur without increasing leg length. The stem/neck angle is 135°. This change will add an alternate porous coating.

Indications for Use:

The indications for use of the total hip replacement prosthesis include: noninflammatory degenerative joint disease including osteoarthritis and avascular necrosis; rheumatoid arthritis; correction of functional deformity; revision procedures where other treatments or devices have failed; and treatment of nonunion, femoral neck and trochanteric fractures of the proximal femur with head involvement, which is unmanageable using other techniques. This stem is to be press-fit.

Predicate Devices:

DJO Surgical Linear Hip Stem, Size 5 - K991325 DJO Surgical Porous Coated Hip Stems - K081679

Comparable Features to Predicate Device(s): Features comparable to predicate devices include the same design features, materials, indications sterilization, packaging and intended use.

Non-Clinical Testing: Fatigue testing of the size 5 stem demonstrated the device's ability to perform under expected conditions. Prior testing of the alternate porous coating in K081679 included shear strength, tensile strength, shear fatigue strength, and rotating beam fatigue.

Clinical Testing: None provided.

1

Image /page/1/Picture/0 description: The image is a circular seal for the Department of Health & Human Services - USA. The seal features the department's name in a circular arrangement around the perimeter. In the center of the seal is an abstract image of an eagle.

Food and Drug Administration 10903 New Hampshire Avenue Document Mail Center - WO66-G609 Silver Spring, MD 20993-0002

FEB 2 4 2012

Encore Medical, L.P. % Ms. Teffany Hutto 9800 Metric Boulevard Austin, TX 78758

Re: K120241

Trade/Device Name: Linear® Porous Coated Hip Stem, Size 5 Regulation Number: 21 CFR 888.3358 Regulation Name: Hip joint metal/polymer/metal semi-constrained porous coated uncemented prosthesis

Regulatory Class: II Product Code: LPH, LZO Dated: January 27th, 2012 Received: January 27th, 2012

Dear Ms. Hutto:

We have reviewed your Section 510(k) premarket notification of intent to market the device referenced above and have determined the device is substantially equivalent (for the indications for use stated in the enclosure) to legally marketed predicate devices marketed in interstate commerce prior to May 28, 1976, the enactment date of the Medical Device Amendments, or to devices that have been reclassified in accordance with the provisions of the Federal Food, Drug, and Cosmetic Act (Act) that do not require approval of a premarket approval application (PMA). You may, therefore, market the device, subject to the general controls provisions of the Act. The general controls provisions of the Act include requirements for annual registration, listing of devices, good manufacturing practice, labeling, and prohibitions against misbranding and adulteration. Please note: CDRH does not evaluate information related to contract liability warranties. We remind you, however, that device labeling must be truthful and not misleading.

If your device is classified (see above) into either class II (Special Controls) or class III (PMA), it may be subject to additional controls. Existing major regulations affecting your device can be found in the Code of Federal Regulations, Title 21, Parts 800 to 898. In addition, FDA may publish further announcements concerning your device in the Federal Register.

2

Page 2 – Ms. Teffany Hutto

Please be advised that FDA's issuance of a substantial equivalence determination does not mean that FDA has made a determination that your device complies with other requirements of the Act or any Federal statutes and regulations administered by other Federal agencies. You must comply with all the Act's requirements, including, but not limited to: registration and listing (21 CFR Part 807); labeling (21 CFR Part 801); medical device reporting (reporting of medical device-related adverse events) (21 CFR 803); good manufacturing practice requirements as set forth in the quality systems (QS) regulation (21 CFR Part 820); and if applicable, the electronic product radiation control provisions (Sections 531-542 of the Act); 21 CFR 1000-1050. If you desire specific advice for your device on our labeling regulation (21 CFR Part 801), please go to http://www.fda.gov/AboutFDA/CentersOffices/CDRH/CDRHOffices/ucm115809.htm for the Center for Devices and Radiological Health's (CDRH's) Office of Compliance. Also, please note the regulation entitled, "Misbranding by reference to premarket notification" (21CFR Part 807.97). For questions regarding the reporting of adverse events under the MDR regulation (21 CFR Part 803), please go to

http://www.fda.gov/MedicalDevices/Safety/ReportaProblem/default.htm for the CDRH's Office of Surveillance and Biometrics/Division of Postmarket Surveillance.

You may obtain other general information on your responsibilities under the Act from the Division of Small Manufacturers, International and Consumer Assistance at its toll-free number (800) 638-2041 or (301) 796-7100 or at its Internet address

http://www.fda.gov/MedicalDevices/Resourcesfor You/Industry/default.htm.

Sincerely yours,

Eunell Keith

Mark N. Melkerson Director Division of Surgical, Orthopedic and Restorative Devices Office of Device Evaluation Center for Devices and . Radiological Health

Enclosure

3

k12024 510(k) Number (if known):

Device Name: Linear Porous Coated Hip Stem - Size 5

Indications for Use:

Linear Porous Coated Hip Stem - Size 5 Indications for Use

The indications for use of the total hip replacement prosthesis include: noninflammatory degenerative joint disease including osteoarthritis and avascular necrosis; rheumatoid arthritis; correction of functional deformity; revision procedures where other treatments or devices have failed; and treatment of nonunion, femoral neck and trochanteric fractures of the proximal femur with head involvement, which is unmanageable using other techniques. This stem is to be pressfit.

Prescription Use _ X (Part 21 CFR 801 Subpart D)

AND/OR

Over-The-Counter Use (21 CFR 801 Subpart C)

(PLEASE DO NOT WRITE BELOW THIS LINE-CONTINUE ON ANOTHER PAGE IF NEEDED)

Concurrence of CDRH, Office of Device Evaluation (ODE)

E. Keith

Division Sign-Oft) Division of Surgical, Orthopedic, and Restorative Devices

510(k) Number K120241

Page 1 of 1